全文获取类型
收费全文 | 1145篇 |
免费 | 136篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 24篇 |
妇产科学 | 9篇 |
基础医学 | 118篇 |
口腔科学 | 27篇 |
临床医学 | 148篇 |
内科学 | 185篇 |
皮肤病学 | 16篇 |
神经病学 | 71篇 |
特种医学 | 49篇 |
外科学 | 138篇 |
综合类 | 188篇 |
一般理论 | 1篇 |
预防医学 | 85篇 |
眼科学 | 43篇 |
药学 | 94篇 |
1篇 | |
中国医学 | 21篇 |
肿瘤学 | 114篇 |
出版年
2023年 | 13篇 |
2022年 | 27篇 |
2021年 | 34篇 |
2020年 | 23篇 |
2019年 | 35篇 |
2018年 | 40篇 |
2017年 | 33篇 |
2016年 | 40篇 |
2015年 | 45篇 |
2014年 | 64篇 |
2013年 | 51篇 |
2012年 | 76篇 |
2011年 | 86篇 |
2010年 | 62篇 |
2009年 | 47篇 |
2008年 | 55篇 |
2007年 | 60篇 |
2006年 | 61篇 |
2005年 | 41篇 |
2004年 | 47篇 |
2003年 | 52篇 |
2002年 | 41篇 |
2001年 | 39篇 |
2000年 | 30篇 |
1999年 | 24篇 |
1998年 | 23篇 |
1997年 | 15篇 |
1996年 | 19篇 |
1995年 | 14篇 |
1994年 | 10篇 |
1993年 | 9篇 |
1992年 | 5篇 |
1991年 | 4篇 |
1990年 | 6篇 |
1989年 | 6篇 |
1988年 | 4篇 |
1987年 | 11篇 |
1986年 | 10篇 |
1985年 | 7篇 |
1984年 | 9篇 |
1983年 | 6篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1976年 | 4篇 |
1974年 | 5篇 |
1965年 | 2篇 |
1908年 | 2篇 |
排序方式: 共有1336条查询结果,搜索用时 15 毫秒
1.
2.
目的 对比分析食管癌病例组与对照组血缘亲属食管癌患病风险,并了解食管癌家族中危险亲属人群患病的新线索.方法 采用病例对照研究方法 ,对食管癌病例组及对照组各720例进行逐层分析,以比较两组各血缘亲属父系、母系食管癌患病危险度(OR)的大小及差异.结果 (1)病例组Ⅰ级亲属食管癌患病危险度(1.34%~2.24%)显著高于对照组(0.78%~1.21%)(P<0.01);Ⅰ级亲属中病例组父母亲食管癌患病危险度为6.11%,显著高于对照组父母亲食管癌患病危险度2.97%(P<0O01).(2)以血缘亲属中父系和母系亲属逐层分析可见,病例组父系食管癌患病危险度(0.87%~1.01%)与母系患病危险度(0.50%~0.79%)均显著高于对照组父系食管癌患病危险度(0.53%~0.65%)与母系患病危险度(0.38%~0.47%)(P<0.05).进一步分析显示,病例组父系中男性亲属与母系中女性亲属,即父系中祖父、父亲、叔伯食管癌患病危险度为2.68%与母系中外祖母、母亲、姨的食管癌患病危险度1.91%均显著高于对照组父系中男性亲属食管癌患病危险度1.50%与母系中女性亲属食管癌患病危险度0.92%(P<0.01).结论 山西省食管癌患者血缘亲属发病危险主要是父亲及其兄弟、母亲及其姐妹,其下代患食管癌风险要大. 相似文献
3.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
4.
5.
6.
7.
8.
目的 探讨与分析快速列车所致火车创伤中关节损伤的变化特点。方法 集1997~2000年火车提速后10214例火车创伤中1279例关节损伤病例,分析在特定条件下的致伤因素、损伤严重程度、损伤类型特点,经AIS-ISS评分证实与预后的关系。结果 提速后关节损伤发生率由提速前33.54%上升到34.12%,死亡率由28.88%上升到30.33%,多关节离断伤由19.84%上升到34.13%,开放性关节损伤由31.71%上升到63.65%,关节离断伤的死亡率由21.19%上升到49.07%。结论 火车创伤无疑是十分严重的损伤,多发伤率远高于其他损伤,治疗棘手,多器官功能不全综合征(MODS)是致死的主要因素。 相似文献
9.
Stanley P. L. Leong Michael E. Granberry Yuan -Ming Zhou Ti -Fen Wang Thomas M. Grogan 《Clinical & experimental metastasis》1991,9(3):301-317
Our goal was to determine the cytotoxic activity of effector cells in lymph nodes with metastatic melanoma. Lymphocytes contained within tumor cells from metastatic lymph nodes of two patients were allowed to proliferate in recombinant IL-2 (rIL-2, 100-1,000 units/ml) after 14–21 days of culture. Each set of lymphocytes showed cytotoxicity against autologous melanoma (AM, mean 72%) at effector to target ratio of 201 and K562 cells (mean 60%) using 4-h chromium-51 release assay. Using unlabeled AM and K562, each AM could partially block the activity against K562, but K562 could not block the activity against AM. These activated lymphocytes underwentin vitro sensitization (IVS) with irradiated AM cells and rIL-2 at 2-week intervals. After repeated IVS over about 50 days, each patient's lymphocytes showed cytotoxicity against AM (mean 54%) but not K562 (mean 5%,P < 0.001). These results indicate that different cytotoxic effector cells were present in the early and late phase of lymphocyte tumor culture. Repeated IVS resulted in the selection of specific cytotoxic T lymphocytes. Cold target inhibition assay demonstrated that melanoma cells contained common and individual AM-associated antigen in addition to K562-associated antigens.This work was supported by Biomedical Research Support Grant of the University of Arizona (no. 2S07 RR05675-20), the Elsa U. Pardee Foundation Grant, partly by the Arizona Chronic Disease Research Commission and partly by CA23074 from the National Institutes of Health, Bethesda, 20892, U.S.A.Recipient of the American Cancer Society Clinical Oncology Career Award, 1987–90. 相似文献
10.
研制了新型壳聚糖胺基衍生物-乙二胺羟丙基壳聚糖(EDA-HPCS),并将其用于固定天门冬酰胺酶,分别考察了甲醛活化载体和戊二醛活化载体对固定化酶活力的影响,结果表明,在适当的固定化条件下,甲醛活化EDA-HPCS的固定化酶活力约为30U/g载体,而戊二醛活化EDA-HPCS固定化酶活力约为16U/g载体。 相似文献